KRAS care partner and advocate Chris Conneran joined an international discussion on how artificial intelligence is shaping cancer care, with a focus on patient trust and transparency.

Once you know your options, the next question is: Am I eligible? Here’s how doctors typically determine if a patient qualifies for a clinical trial or specific therapy—regardless of cancer type. 6 things that matter...

..just been diagnosed—or are navigating next step—you’re not alone. Cancer care has changed dramatically in the last decade. Today, you may have more treatment choices than ever before. This post is designed to help you understand your options and feel confident asking the right questions.